Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Muscular Atrophy × Cyproheptadine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Spinal Cord Neoplasms 1 Recurrence 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Optic Nerve Glioma 1 Oligodendroglioma 1 Neoplasms 1 Myelodysplastic-Myeloproliferative Diseases 1 Myelodysplastic Syndromes 1 Muscular Atrophy 1 Medulloblastoma 1 Lymphoma 1 Leukemia, Myelomonocytic, Juvenile 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1 Leukemia, Myeloid, Accelerated Phase 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia, Hairy Cell 1 Leukemia 1 Familial ependymoma 1 Dendritic Cell Sarcoma, Interdigitating 1 Choroid Plexus Neoplasms 1 Child Nutrition Disorders 1 Central Nervous System Neoplasms 1 Cachexia 1 Burkitt Lymphoma 1 Brain Neoplasms 1 Blast Crisis 1 Astrocytoma 1

Interventions

rimabotulinumtoxinB 1 ostarine 1 Standard of Care 1 Olanzapine 1 Enteral Nutrition 1 Cyproheptadine 1 Creatine 1 Botulinum Toxins, Type A 1 Acetylcysteine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06175273 2025-09-18

POINT

University of Kentucky

Phase 2/3 Completed

Muscular Atrophy, Neoplasms, Child Nutrition Disorders

Data powered by HemOnc (CC BY 4.0) Colophon ⚡